Could 'good' immune cells prevent transplant complications in blood cancer?
NCT ID NCT05088356
First seen Jan 04, 2026 · Last updated Apr 29, 2026 · Updated 16 times
Summary
This early-phase trial tests a new approach for people with advanced blood cancers who are getting a stem cell transplant. Instead of using strong drugs to prevent graft-versus-host disease (a common complication where donor cells attack the patient), researchers will give specially prepared donor immune cells (regulatory T-cells) to help control the immune response. The goal is to see if this can reduce side effects and improve survival. About 77 participants will be enrolled.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROMES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Stanford University
RECRUITINGStanford, California, 94304, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.